Skip to content

Study · Case report or series · n = 2 · 2026

1 result

Treatment Approaches for Obesity in Children With Heterozygous MC4R Variants.

Salama M, Saba L, Valdez L, Lteif A, Kumar S

Clinical obesity1 Feb 2026Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In two adolescents with pathogenic or likely pathogenic MC4R mutations, semaglutide treatment was followed by significant weight improvement.

    In plain wordsIn two teenagers with a gene change that causes obesity, weight improved on semaglutide. Two cases cannot show it works generally.

    Outcome
    DecreaseWeight improvement in adolescents with MC4R mutations
    Study

    n = 2

    Outcome group
    Body weight · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    We describe significant improvement in weight in three patients with pathogenic or likely pathogenic MC4R mutations; two adolescents treated with semaglutide, and a younger child treated with metformin and topiramate.
    1 context sentence
    Title · context
    Treatment Approaches for Obesity in Children With Heterozygous MC4R Variants.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.